The American Society of Echocardiography (ASE) has joined the ABIM Foundation and 37 other specialty societies as part of Choosing Wisely, an effort to reduce inappropriate tests and procedures to improve care. This initiative aims to spark conversations about appropriate care between physicians and patients to help physicians provide the right care at the right time for the right patient.
Guerbet announced that the Medical Imaging Drugs Advisory Committee to U.S. Food and Drug Administration (FDA) has voted unanimously by votes of 17 to zero to recommend that FDA approve the New Drug Application (NDA) for Dotarem (gadoterate meglumine) for adults, and for pediatric use for children two years of age and older. The committee voted 10 to six (with one member abstaining) not to recommend at this time approval of the indication for children under two years of age.
CardioLogical Solutions is an emerging cardiovascular device company formed by the merger of Emboline and VasoStitch and its breakthrough platform of accessory devices for transcatheter aortic valve replacement (TAVR) procedures.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Biosense Webster showcased its portfolio of cutting edge innovative electrophysiology technologies at the 2013 Boston AF meeting.
In response to the astounding percentage of inappropriate and non-compliant ICD, CRT-P and CRT-D device implantations each year, Think Tank Medical has developed and released its CMS ICD Application, available for the iPhone and iPad to ensure that 100 percent of patients screened meet the evidence-based criteria for implantation.
TeraRecon received the North American New Product Innovation Award in Medical Imaging Informatics from the respected independent research firm Frost and Sullivan. This is the seventh time that TeraRecon Inc. has been recognized with a Best Practices award from Frost and Sullivan, and the third time since 2010, following the European Company of the Year Award in the category of Medical Imaging, Advanced Visualization Applications, and the North American Growth Leadership of the Year Award.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

Boston Scientific received CE mark approval for the Promus Premier everolimus-eluting platinum chromium coronary stent system, the company's next-generation durable polymer drug-eluting stent (DES) technology. The Promus Premier is designed to improve DES performance with a new delivery system and redesigned stent architecture that improves radial, axial strength and deliverability.
As health systems are under increasing pressure to share data across systems to improve and expand their networks of care, CardioNet Inc. and AirStrip have entered into a partnership agreement to develop and co-market an integrated solution for mobile patient monitoring.
Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of its Advisa DR MRI (magnetic resonance imaging) SureScan pacing system. The Advisa MRI system is Medtronic’s second-generation MR-conditional pacemaker and is the first system to combine the most advanced pacing technology with proven MRI access.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Computed tomography (CT) radiation dose can result in unnecessarily high exposures, placing patients at increased risk of cancer and other conditions. Inappropriate radiation doses have raised public concerns and attracted national media attention.

Hospitals, clinics and office-based physicians are increasingly turning to electronic medical records (EMRs) as they prepare for the impact of the Patient Protection and Affordable Health Care (PPAHC) act, says Albert Woodard, CEO of Atlanta-based Business Computer Applications, a company devoted to digitizing medical records.
The Society of Interventional Radiology (SIR), an international organization of doctors, scientists and allied health professionals dedicated to improving public health through minimally invasive, image-guided treatments, joined as a member of the "Rethink Varicose Veins" coalition, an alliance of organizations united to drive public awareness of the risks of varicose veins and chronic venous insufficiency.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

St. Jude Medical Inc. announced enrollment of the first patient in the EnligHTN II trial. This post-market clinical study will further evaluate the safety and efficacy of the EnligHTN renal denervation system in patients with uncontrolled hypertension.
St. Jude Medical Inc announced the first patient implant of its 25 mm Portico Transcatheter Aortic Heart Valve using the Transfemoral Delivery System in its ongoing European trial. The Portico valve system offers a minimally invasive treatment option for patients with severe aortic stenosis — a narrowing of the aortic valve that obstructs blood flow from the heart.
Nuclear Medicine Information Systems LLC (NMIS) and BioDose LLC have been renamed and rebranded as ec2 Software Solutions, company officials announced.